Unduh Oncology Nursing Drug Handbook - v3.5.13

Harap unduh dan bagikan Oncology Nursing Drug Handbook - v3.5.13, salah satu dari Aplikasi unggulan di kategori Kedokteran.
Plus, beberapa Aplikasi lainnya yang dapat Anda unduh sebagai MCQ Abubakr (ASU), X-RAY WOW, NYP, Medical Dictionary Free & Offline - Diseases, Jan Aushadhi Sugam (BPPI), Pacify. Jika Anda merasa puas dengan Oncology Nursing Drug Handbook - v3.5.13.

Dirilis oleh Skyscape Medpresso Inc, Oncology Nursing Drug Handbook - v3.5.13 adalah salah satu aplikasi telepon seluler gratis dan terbaik yang tersedia saat ini. Terletak di Kedokteran kategori toko aplikasi.

Sistem operasi minimum untuk Oncology Nursing Drug Handbook - v3.5.13 adalah Android 5.0+ dan lebih tinggi. Jadi Anda harus memperbarui ponsel Anda jika Anda belum melakukannya.

Di APKDroid, Anda akan mendapatkan Oncology Nursing Drug Handbook - v3.5.13 unduhan gratis APK, dengan versi terbaru adalah 3.5.13, tanggal publikasi 2020-06-25, ukuran file 8.4 MB.Menurut statistik dari Google Play Store, ada sekitar 1000 unduhan. Aplikasi yang diunduh atau dipasang satu per satu di Android dapat diperbarui jika Anda mau. Perbarui aplikasi Anda juga. Memberi Anda akses ke fitur terbaru dan meningkatkan keamanan dan stabilitas aplikasi. Nikmati sekarang !!!

Written especially for nurses caring for patients with cancer, the 2020-2021 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. This essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration.

DESCRIPTION
Completely revised and updated, the 2020-2021 Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer. It also offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for drugs recently approved by the FDA.

Key Features

- Provides valuable information on effective symptom management, patient education, and chemotherapy administration.
- Completely revised and updated, includes separate chapters on molecular and immunologic/biologic targeted therapies
- Provides fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer
- Offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for recently FDA approved drugs
- New drugs include: apalutamide (Erleada™), calaspargase pegol-mknl (Asparlas™), Daunorubicin and cytarabine liposome for injection (Vyxeos®), glucarpidase (Voraxaze®), alpelisib (Piqray®), binimetinib (Mektovi®), dacomitinib (Vizimpro®), Duvelisib (Copiktra®), encorafenib (Braftovi®), erdafitinib (Balversa™), lorlatinib (Lorbrena®), anakinra (Kineret®), baricitinib (Olumiant®), sarilumab (Kevzara®), aprepitant injectable emulsion (Cinvanti®), granisetron hydrochloride extended-release injection (Sustol®), letermovir (Prevymis™), omadacycline (Nuzyra™), meropenem/vaborbactam (Vabomere™), Plazomicin (Zemdri™), baloxavir marboxil (Xofluza™), imipenem/cilastatin sodium/relebactam (Recarbrio™), eravacycline (Xerava™), delafloxacin (Baxdela™)

Faster download with slow internet connectivity